Heparin binding growth factor pseudogene 1 (HDGFP1)

Heparin binding growth factor pseudogene 1 (HDGFP1) is classified as a pseudogene, meaning it is a segment of DNA that resembles a gene but is not believed to produce a functional protein product. There is no evidence supporting a role for HDGFP1 as a therapeutic target, nor for involvement in canonical molecular pathways, diseases, or drug interactions. It does not belong to recognized molecular families such as receptors, enzymes, transporters, or transcription factors. No biological functions, disease associations, drug interactions, biomarker roles, or known safety concerns are documented for HDGFP1[4]. Key context: - Pseudogene refers to a genomic sequence that resembles a gene but is generally considered nonfunctional in terms of encoding a protein. Pseudogenes typically arise from duplication or retrotransposition events and often accumulate disabling mutations over time. - There is a different, functional "heparin-binding growth factor" called hepatoma-derived growth factor (HDGF), which is a real therapeutic target in cancer and other proliferative diseases, but HDGFP1 is not the same and should not be confused with it[1][4]. - The entry "HDGFP1" appears to be included in genomic databases for completeness of annotation but is not an active research or clinical target, nor does it play any established biological, pharmacological, or disease-modifying role. If you are seeking information on a growth factor or related therapeutic target, confirm the specific gene or protein of interest, as "HDGFP1" refers to a pseudogene, not an actionable molecular target[4].

None known